In the article by Kopelovich et al., entitled “Peroxisome proliferator-activated receptor modulators as potential chemopreventive agents,” which appeared in the March 2002 issue of MCT (pp. 357–363), Dr. Judith R. Fay’s affiliation was listed incorrectly as National Cancer Institute, Division of Cancer Prevention, Bethesda, MD 20892-7322. Dr. Fay’s correct affiliation is CCS Associates, Mountain View, California 94043.
Molecular Cancer Therapeutics
2002